At PierianDx, we are well-versed in helping healthcare organizations implement clinical next generation sequencing (NGS) testing programs. But beyond implementation of genomic testing programs at individual institutions, what must happen to make this technology more readily available to all?
At the recent Personalized Medicine World Conference (PMWC), several industry leaders set about to answer this question. Moderated by Allison Ballmer, Agilent Technologies, Rakesh Nagarajan, PierianDx; Joe Ferrara, Boston Healthcare; and Paul Billings, Natera; each share their unique perspectives.
PMWC19_Track 2_d2_9_Hurdles of Making Clinical Sequencing a Reality from PMWC Intl on Vimeo.
